📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease? (2023)

First Author: Bellingrath J

Attributed to: University of Oxford – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fnmol.2023.1092913

PubMed Identifier: 37293541

Publication URI: http://europepmc.org/abstract/MED/37293541

Type: Journal Article/Review

Parent Publication: Frontiers in Molecular Neuroscience

ISSN: 1662-5099